Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1048-1053.DOI: 10.12114/j.issn.1007-9572.2023.0330
Special Issue: 泌尿系统疾病最新文章合辑; 老年人群健康最新文章合辑; 老年问题最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2023-03-15
Revised:
2023-07-25
Published:
2024-03-20
Online:
2023-12-19
Contact:
XU Chengyan
通讯作者:
许成燕
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0330
组别 | 人数 | 肾功能异常 | 尿蛋白阳性 |
---|---|---|---|
60~69岁组 | 6 901 | 129(1.87) | 834(12.09) |
70~79岁组 | 4 867 | 286(5.88) | 662(13.60) |
80~89岁组 | 1 128 | 224(19.86) | 171(15.16) |
≥90岁组 | 184 | 74(40.22) | 23(12.50) |
χ2值 | 1 059.282 | 11.454 | |
P值 | <0.001 | 0.010 |
Table 1 Results of detection rates of positive renal dysfunction and proteinuria in different age groups
组别 | 人数 | 肾功能异常 | 尿蛋白阳性 |
---|---|---|---|
60~69岁组 | 6 901 | 129(1.87) | 834(12.09) |
70~79岁组 | 4 867 | 286(5.88) | 662(13.60) |
80~89岁组 | 1 128 | 224(19.86) | 171(15.16) |
≥90岁组 | 184 | 74(40.22) | 23(12.50) |
χ2值 | 1 059.282 | 11.454 | |
P值 | <0.001 | 0.010 |
组别 | 例数 | 年龄[M(P25,P75),岁] | 性别(男/女) | 糖尿病[名(%)] | 高血压[名(%)] | BMI [M(P25,P75),kg/m2] | BUN [M(P25,P75),mmol/L] | Scr [M(P25,P75),mmol/L] |
---|---|---|---|---|---|---|---|---|
肾功能正常组 | 12 367 | 69(66,73) | 5 424/6 943 | 2 552(20.80) | 8 208(66.40) | 24.8(22.7,27.0) | 5.77(4.90,6.77) | 62.00(54.00,72.00) |
肾功能异常组 | 713 | 78(71,85) | 325/388 | 386(54.10) | 617(86.80) | 24.9(22.4,27.1) | 8.91(7.37,11.14) | 108.00(92.00,123.20) |
Z(χ2)值 | -24.747 | 0.813a | 447.652a | 127.617a | -0.524 | -34.273 | -43.025 | |
P值 | <0.001 | 0.367 | <0.001 | <0.001 | 0.600 | <0.001 | <0.001 | |
组别 | ACR [M(P25,P75),mg/g] | TC [M(P25,P75),mmol/L] | TG [M(P25,P75),mmol/L] | HDL-C [M(P25,P75),mmol/L] | LDL-C [M(P25,P75),mmol/L] | Hb [M(P25,P75),g/L] | ||
肾功能正常组 | 20(20,20) | 5.12(4.46,5.83) | 1.29(0.95,1.81) | 1.46(1.26,1.72) | 3.06(2.48,3.66) | 135(127,144) | ||
肾功能异常组 | 20(10,25) | 4.89(4.11,5.72) | 1.51(1.06,2.07) | 1.36(1.15,1.61) | 2.83(2.16,3.49) | 124(113,136) | ||
Z(χ2)值 | -2.234 | -5.243 | -6.546 | -8.159 | -6.031 | -17.999 | ||
P值 | 0.025 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 2 Comparison of general information and laboratory examination data between the abnormal renal function group and normal renal function group
组别 | 例数 | 年龄[M(P25,P75),岁] | 性别(男/女) | 糖尿病[名(%)] | 高血压[名(%)] | BMI [M(P25,P75),kg/m2] | BUN [M(P25,P75),mmol/L] | Scr [M(P25,P75),mmol/L] |
---|---|---|---|---|---|---|---|---|
肾功能正常组 | 12 367 | 69(66,73) | 5 424/6 943 | 2 552(20.80) | 8 208(66.40) | 24.8(22.7,27.0) | 5.77(4.90,6.77) | 62.00(54.00,72.00) |
肾功能异常组 | 713 | 78(71,85) | 325/388 | 386(54.10) | 617(86.80) | 24.9(22.4,27.1) | 8.91(7.37,11.14) | 108.00(92.00,123.20) |
Z(χ2)值 | -24.747 | 0.813a | 447.652a | 127.617a | -0.524 | -34.273 | -43.025 | |
P值 | <0.001 | 0.367 | <0.001 | <0.001 | 0.600 | <0.001 | <0.001 | |
组别 | ACR [M(P25,P75),mg/g] | TC [M(P25,P75),mmol/L] | TG [M(P25,P75),mmol/L] | HDL-C [M(P25,P75),mmol/L] | LDL-C [M(P25,P75),mmol/L] | Hb [M(P25,P75),g/L] | ||
肾功能正常组 | 20(20,20) | 5.12(4.46,5.83) | 1.29(0.95,1.81) | 1.46(1.26,1.72) | 3.06(2.48,3.66) | 135(127,144) | ||
肾功能异常组 | 20(10,25) | 4.89(4.11,5.72) | 1.51(1.06,2.07) | 1.36(1.15,1.61) | 2.83(2.16,3.49) | 124(113,136) | ||
Z(χ2)值 | -2.234 | -5.243 | -6.546 | -8.159 | -6.031 | -17.999 | ||
P值 | 0.025 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 人数 | 年龄[M(P25,P75),岁] | 性别(男/女) | 糖尿病[名(%)] | 高血压[名(%)] | BMI [M(P25,P75),kg/m2] | BUN [M(P25,P75),mmol/L] |
---|---|---|---|---|---|---|---|
非蛋白尿组 | 11 390 | 69(66,74) | 4 904/6 486 | 2 467(21.80) | 7 690(67.51) | 24.8(22.7,27.0) | 5.82(4.93,6.88) |
蛋白尿组 | 1 690 | 70(66,74) | 845/845 | 471(28.00) | 1 135(67.16) | 25.2(23.0,27.4) | 6.14(5.14,7.31) |
Z(χ2)值 | -2.735 | 28.812a | 32.789a | 0.085a | 22.745b | -7.079 | |
P值 | <0.001 | <0.001 | <0.001 | 0.771 | <0.001 | <0.001 | |
组别 | Scr [M(P25,P75),mmol/L] | TC [M(P25,P75),mmol/L] | TG [M(P25,P75),mmol/L] | HDL-C [M(P25,P75),mmol/L] | LDL-C [M(P25,P75),mmol/L] | Hb [M(P25,P75),g/L] | |
非蛋白尿组 | 63.00(54.00,73.40) | 5.12(4.46,5.83) | 1.30(0.95,1.81) | 1.47(1.26,1.72) | 3.06(2.48,3.66) | 135(127,144) | |
蛋白尿组 | 66.00(55.98,79.00) | 5.03(4.35,5.78) | 1.35(0.99,1.91) | 1.41(1.21,1.66) | 2.98(2.39,3.60) | 135(126,144) | |
Z(χ2)值 | -7.407 | -3.249 | -3.425 | -6.054 | -2.902 | -0.563 | |
P值 | <0.001 | 0.001 | 0.001 | <0.001 | 0.004 | 0.573 |
Table 3 Comparison of general data and laboratory examination data between the proteinuria group and non-proteinuria group
组别 | 人数 | 年龄[M(P25,P75),岁] | 性别(男/女) | 糖尿病[名(%)] | 高血压[名(%)] | BMI [M(P25,P75),kg/m2] | BUN [M(P25,P75),mmol/L] |
---|---|---|---|---|---|---|---|
非蛋白尿组 | 11 390 | 69(66,74) | 4 904/6 486 | 2 467(21.80) | 7 690(67.51) | 24.8(22.7,27.0) | 5.82(4.93,6.88) |
蛋白尿组 | 1 690 | 70(66,74) | 845/845 | 471(28.00) | 1 135(67.16) | 25.2(23.0,27.4) | 6.14(5.14,7.31) |
Z(χ2)值 | -2.735 | 28.812a | 32.789a | 0.085a | 22.745b | -7.079 | |
P值 | <0.001 | <0.001 | <0.001 | 0.771 | <0.001 | <0.001 | |
组别 | Scr [M(P25,P75),mmol/L] | TC [M(P25,P75),mmol/L] | TG [M(P25,P75),mmol/L] | HDL-C [M(P25,P75),mmol/L] | LDL-C [M(P25,P75),mmol/L] | Hb [M(P25,P75),g/L] | |
非蛋白尿组 | 63.00(54.00,73.40) | 5.12(4.46,5.83) | 1.30(0.95,1.81) | 1.47(1.26,1.72) | 3.06(2.48,3.66) | 135(127,144) | |
蛋白尿组 | 66.00(55.98,79.00) | 5.03(4.35,5.78) | 1.35(0.99,1.91) | 1.41(1.21,1.66) | 2.98(2.39,3.60) | 135(126,144) | |
Z(χ2)值 | -7.407 | -3.249 | -3.425 | -6.054 | -2.902 | -0.563 | |
P值 | <0.001 | 0.001 | 0.001 | <0.001 | 0.004 | 0.573 |
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
高血压 | 1.212 | 0.120 | 102.277 | <0.001 | 3.361(2.657~4.251) |
糖尿病 | 1.423 | 0.088 | 264.184 | <0.001 | 4.151(3.496~4.28) |
高TG血症 | 0.560 | 0.110 | 25.754 | <0.001 | 1.751(1.410~2.173) |
贫血 | 1.837 | 0.127 | 207.942 | <0.001 | 6.276(4.889~8.055) |
低HDL-C血症 | 0.547 | 0.140 | 15.299 | <0.001 | 1.728(1.314~2.272) |
蛋白尿 | 0.765 | 0.103 | 54.867 | <0.001 | 2.149(1.755~2.632) |
70~79岁 | 1.062 | 0.112 | 90.237 | <0.001 | 2.891(2.323~3.600) |
80~89岁 | 2.069 | 0.126 | 269.989 | <0.001 | 7.915(6.184~10.131) |
≥90岁 | 2.847 | 0.198 | 205.870 | <0.001 | 17.239(11.684~25.434) |
Table 4 Multivariate Logistic regression analysis of influencing factors of renal dysfunction
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
高血压 | 1.212 | 0.120 | 102.277 | <0.001 | 3.361(2.657~4.251) |
糖尿病 | 1.423 | 0.088 | 264.184 | <0.001 | 4.151(3.496~4.28) |
高TG血症 | 0.560 | 0.110 | 25.754 | <0.001 | 1.751(1.410~2.173) |
贫血 | 1.837 | 0.127 | 207.942 | <0.001 | 6.276(4.889~8.055) |
低HDL-C血症 | 0.547 | 0.140 | 15.299 | <0.001 | 1.728(1.314~2.272) |
蛋白尿 | 0.765 | 0.103 | 54.867 | <0.001 | 2.149(1.755~2.632) |
70~79岁 | 1.062 | 0.112 | 90.237 | <0.001 | 2.891(2.323~3.600) |
80~89岁 | 2.069 | 0.126 | 269.989 | <0.001 | 7.915(6.184~10.131) |
≥90岁 | 2.847 | 0.198 | 205.870 | <0.001 | 17.239(11.684~25.434) |
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
糖尿病 | 0.227 | 0.061 | 13.748 | <0.001 | 1.255(1.113~1.415) |
男性 | 0.179 | 0.058 | 9.713 | 0.002 | 1.197(1.069~1.339) |
肥胖 | 0.238 | 0.066 | 12.906 | <0.001 | 1.269(1.114~1.445) |
高TG血症 | 0.178 | 0.073 | 5.952 | 0.015 | 1.194(1.036~1.378) |
Scr | 0.005 | 0.001 | 11.054 | 0.001 | 1.005(1.002~1.007) |
BUN | 0.006 | 0.016 | 13.517 | <0.001 | 1.062(1.029~1.097) |
Table 5 Multivariate Logistic regression analysis of influencing factors of proteinuria
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
糖尿病 | 0.227 | 0.061 | 13.748 | <0.001 | 1.255(1.113~1.415) |
男性 | 0.179 | 0.058 | 9.713 | 0.002 | 1.197(1.069~1.339) |
肥胖 | 0.238 | 0.066 | 12.906 | <0.001 | 1.269(1.114~1.445) |
高TG血症 | 0.178 | 0.073 | 5.952 | 0.015 | 1.194(1.036~1.378) |
Scr | 0.005 | 0.001 | 11.054 | 0.001 | 1.005(1.002~1.007) |
BUN | 0.006 | 0.016 | 13.517 | <0.001 | 1.062(1.029~1.097) |
[1] |
|
[2] |
|
[3] |
|
[4] |
王善志,朱永俊,唐文庄,等. 中国成人及老年人群慢性肾脏病患病率Meta分析[J]. 中国老年学杂志,2017,37(21):5384-5388. DOI:10.3969/j.issn.1005-9202.2017.21.076.
|
[5] |
葛均波,徐永健. 内科学[M]. 8版. 北京:人民卫生出版社,2013.
|
[6] |
|
[7] |
孙治平,武晓春,戴瑛,等. 尿微量白蛋白/肌酐在老年健康体检人群慢性肾脏病筛查中的应用[J]. 实用老年医学,2021,35(3):278-281. DOI:10.3969/j.issn.1003-9198.2021.03.017.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
陈建峰,李莹. 上海市浦东城乡老年人估算肾小球滤过率及危险因素分析[J]. 中华全科医学,2017,15(5):823-826. DOI:10.16766/j.cnki.issn.1674-4152.2017.05.029.
|
[12] |
黄燕萍,茹倩影,张旦欢,等. 2012—2016年上海市长宁区老年人群慢性肾脏病患病率调查研究[J]. 中国全科医学,2020,23(17):2215-2218. DOI:10.12114/j.issn.1007-9572.2019.00.566.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
陈金玲,陈志晓,黎莉,等. 肾病诊治中尿微量白蛋白与尿肌酐比值测定的临床意义[J]. 中国实用医药,2019,14(23):49-50. DOI:10.14163/j.cnki.11-5547/r.2019.23.023.
|
[19] |
陈学东,潘灏. 慢性肾脏病随机尿、晨尿微量白蛋白肌酐比值与24h尿白蛋白的相关性分析[J]. 医学理论与实践,2021,34(5):732-734,757. DOI:10.19381/j.issn.1001-7585.2021.05.004.
|
[20] |
温远生,何志良,贺靖. 血清胱抑素C与尿微量白蛋白/肌酐比值联合检测在糖尿病早期肾损伤中的诊断价值分析[J]. 世界最新医学信息文摘,2021,21(75):477-478. DOI:10.3969/j.issn.1671-3141.2021.75.232.
|
[1] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[2] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[3] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[4] | CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan. Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors [J]. Chinese General Practice, 2025, 28(26): 3294-3299. |
[5] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[6] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[7] | JI Bing, JIANG Dudu, CHEN Chen, ZHENG Yanling, SHI Jianwei, FANG Lizheng, DU Xueping. Constructing a Comprehensive Community Clinical Pathway for Herpes Zoster under Graded Treatment Framework [J]. Chinese General Practice, 2025, 28(25): 3110-3118. |
[8] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[9] | YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004. |
[10] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[11] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[12] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
[13] | WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914. |
[14] | DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan. Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(23): 2885-2893. |
[15] | SHI Jiarui, WANG Zili, ZHANG Xueqing, SONG Yulei, XU Guihua, BAI Yamei. The Current Status of Initial Cognitive Screening Services in Community-based Cognitive Services Centers in Nanjing [J]. Chinese General Practice, 2025, 28(22): 2784-2790. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||